Cathay Biotech (China) Market Value
| 688065 Stock | 45.01 0.36 0.79% |
| Symbol | Cathay |
Cathay Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cathay Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cathay Biotech.
| 12/19/2023 |
| 12/13/2024 |
If you would invest 0.00 in Cathay Biotech on December 19, 2023 and sell it all today you would earn a total of 0.00 from holding Cathay Biotech or generate 0.0% return on investment in Cathay Biotech over 360 days. Cathay Biotech is related to or competes with Suofeiya Home, Meinian Onehealth, Dezhan HealthCare, PKU HealthCare, Zoy Home, DO Home, and Vohringer Home. Cathay Biotech is entity of China. It is traded as Stock on SHG exchange. More
Cathay Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cathay Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cathay Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.58 | |||
| Information Ratio | 0.0852 | |||
| Maximum Drawdown | 23.44 | |||
| Value At Risk | (4.41) | |||
| Potential Upside | 6.97 |
Cathay Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cathay Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cathay Biotech's standard deviation. In reality, there are many statistical measures that can use Cathay Biotech historical prices to predict the future Cathay Biotech's volatility.| Risk Adjusted Performance | 0.0902 | |||
| Jensen Alpha | 0.474 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | 0.1332 | |||
| Treynor Ratio | (1.58) |
Cathay Biotech Backtested Returns
Cathay Biotech appears to be not too volatile, given 3 months investment horizon. Cathay Biotech secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15% return per unit of risk over the last 3 months. By analyzing Cathay Biotech's technical indicators, you can evaluate if the expected return of 0.63% is justified by implied risk. Please makes use of Cathay Biotech's Downside Deviation of 2.58, mean deviation of 2.56, and Risk Adjusted Performance of 0.0902 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Cathay Biotech holds a performance score of 11. The firm shows a Beta (market volatility) of -0.28, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Cathay Biotech are expected to decrease at a much lower rate. During the bear market, Cathay Biotech is likely to outperform the market. Please check Cathay Biotech's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Cathay Biotech's price patterns will revert.
Auto-correlation | 0.29 |
Poor predictability
Cathay Biotech has poor predictability. Overlapping area represents the amount of predictability between Cathay Biotech time series from 19th of December 2023 to 16th of June 2024 and 16th of June 2024 to 13th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cathay Biotech price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current Cathay Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.29 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 30.01 |
Cathay Biotech lagged returns against current returns
Autocorrelation, which is Cathay Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cathay Biotech's stock expected returns. We can calculate the autocorrelation of Cathay Biotech returns to help us make a trade decision. For example, suppose you find that Cathay Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cathay Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cathay Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cathay Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cathay Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Cathay Biotech Lagged Returns
When evaluating Cathay Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cathay Biotech stock have on its future price. Cathay Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cathay Biotech autocorrelation shows the relationship between Cathay Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Cathay Biotech.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Cathay Stock
Cathay Biotech financial ratios help investors to determine whether Cathay Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cathay with respect to the benefits of owning Cathay Biotech security.